Abstract
This chapter provides an outlook for future projections of growth in the livestock industry and the likely resultant demands of the animal health products market.
It describes the animal health industries landscape that, in recent years, has been dominated by acquisitions and mergers. Mergers have allowed the newly formed companies to expand their portfolios into new areas of prospective growth which include the biotech area. The chapter concludes that such changes have been facilitated by collaborations or licensing agreements with small companies holding patent protected technologies for niche markets. Indeed, the opportunity for partnerships and alliances has become the core of a new business strategy for big pharma.
Any views or opinions presented in this document are solely those of the author and do not necessarily represent those of the company
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Thornton PK (2010) Livestock production: recent trends, future prospects. Phil Trans R Soc B 365:2853–2867
Food and Agriculture Organization of the United Nations’ statistical database (FAOStat) (Sept 2011). http://faostat.fao.org/site/339/default.aspx
Godfray HCJ, Crute IR, Haddad L, Lawrence D, Muir JF, Nisbett N, Pretty J, Robinson S, Toulmin C, Whiteley R (2010) The future of the global system. Phil Trans R Soc B 365:2769–2777
Evans T (2009) Global animal health industry and trends, a US perspective. AVDA Congress: Thriving in Dynamic Times, St. Petersburg, FL
Foster TP, Abraham SS (in press) Veterinary dosage forms. In: Swarbrick J (ed) Encyclopedia of pharmaceutical science and technology, 4th edn. Informa Healthcare, London
Vetnosis Limited (2009) Veterinary report. Edinburgh, United Kingdom
Perry BD, Grace D, Sones K (2011) Current drivers and future directions of global livestock disease dynamics. Proc Natl Acad Sci USA 108:1–7
Rathbone M, Brayden D (2009) Controlled release drug delivery in farmed animals: commercial challenges and academic opportunities. Curr Drug Deliv 6:383–390
OECD Science, Technology and Industry Scoreboard 2011
Brunner CS (Jun 2004) Challenges and opportunities in emerging drug delivery technologies, PG report. Emerging Drug Delivery Technologies, # 0403
Vancauwengerghe CE (2011) The reshaping of pharmaceutical industry landscape: partnerships and alliances are the core of new business strategy. Drug Dev Deliv 11:8–15
Kipper M (2010) Controlled-release immunogenic formulations to modulate immune response. US patent 7,858,093B1
Sheppard NF, Santini JT, Cima MJ, Langer RS, Ausiello D (2008) Method for wirelessly monitoring implanted medical device. US patent application US2008/0221555A1
Sheppard NF, Santini JT, Cima MJ, Langer RS, Ausiello D (2007) Microchip reservoir devices using wireless transmission of power and data. US patent 7,226,442B2
Polat BE, Hart D, Langer RS, Blankschtein D (2011) Ultrasound-mediated transdermal drug delivery: mechanisms, scope, and emerging trends. J Control Release 152:330–348
Wu D, Chu CC, Carozza J (2011) Injectable microspheres. US patent 8,034,383
Wu D, Chu CC, Carozza J (2008) Hydrogel compositions comprising serum albumins for vaccines. US patent application 20080226725A1
Krippner GY, Williams C, Kelly B, Henderson S, Wu Z, Razzino P (2010) Targeted polylysine dendrimer therapeutic agent. US patent application 20100292148A1
Verity N (2011) Controlled-release anesthetic delivery systems, US patent application 20110009451
Chen G, Kleiner L, Houston P, Nathan A, Rosenblatt J (2007) Implantable caprolactone-based polyester elastomeric depot compositions and uses thereof. US patent application 20070184084A1
Ozeki Y, Izumi K, Watanabe Y, Okamoto H, Danjo K (2005) Advanced dry-coated tablets as a solid coating technology-1. Pharm Tech Jpn 21:1407–1413
Chan Y, Meyrueix R, Kravtzoff R, Nicolas F, Lundstrom K (2007) Review on Medusa®: a polymer-based sustained release technology for protein and peptide drugs. Expert Opin Drug Deliv 4:441–451
Emanuel N, Neuman M, Barak S (2010) Sustained-release drug carrier composition. World patent application WO2010007623
Wissink J, Van Rijn C, Nijdam W, Goeting C, Heskamp I, Veldhuis G (2005) Device for generating microspheres from a fluid, method of injecting at least one first fluid into a second fluid, and an injection plate. World patent application 2005115599 A1
Veldhuis G, Gironès M, Bingham D (2009) Monodisperse microspheres for parenteral drug delivery. Drug Deliv Technol 9:24–31
Alur H, Harwick J, Mondal P, Johnston T (2009) Self solidifying bioerodible barrier implant. World patent application 2009073658 A1
Antineoplastic agents (2010) In: Kahn CM (ed) Merck veterinary manual, 10th edn. Merck Sharp & Dohme Corporation, New Jersey
Oborne M (2010) The bioeconomy to 2030: designing a policy agenda. OECD Observer, 278
Reviere J (2007) The future of veterinary therapeutics: a glimpse towards 2030. Vet J 174:463–471
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Controlled Release Society
About this chapter
Cite this chapter
Sabnis, S., Rathbone, M.J. (2013). Animal Health Markets and Opportunities: Farmed Animal Landscape. In: Rathbone, M., McDowell, A. (eds) Long Acting Animal Health Drug Products. Advances in Delivery Science and Technology. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-4439-8_1
Download citation
DOI: https://doi.org/10.1007/978-1-4614-4439-8_1
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-4438-1
Online ISBN: 978-1-4614-4439-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)